(Q83619565)
Statements
Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer (English)
J O'Shaughnessy
Y Wu
M M Amonkar
B H Sherrill
C Ellis
J Baselga
K L Blackwell